Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 7

Study Type

Observational 6Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5CNS 1

Conditions

Breast Neoplasms 8Neoplasms 7Uterine Cervical Neoplasms 5Head and Neck Neoplasms 5Prostatic Neoplasms 4Melanoma 4Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Hematologic Neoplasms 3Glioma 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neuroblastoma 2Lymphedema 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Squamous Cell 2Atypical Squamous Cells of the Cervix 2Astrocytoma 2Xeroderma Pigmentosum 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Trichothiodystrophy Syndromes 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Neoplasms × Restraint, Physical × Clear all
NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated
66 enrolled
CNS

Neoplasms, Neuroblastoma

NCT05594693 2026-01-16

Integrative Health Interventions in Symptom Management of Pediatric Patients

University of Colorado, Denver

Completed
100 enrolled
Tumor-Agnostic

Neoplasms

NCT02296450 2025-12-19

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Memorial Sloan Kettering Cancer Center

Recruiting
1,025 enrolled
Tumor-Agnostic

Neoplasms

NCT04732273 2025-09-23

SCCSS-FU

University of Bern

Recruiting
3,000 enrolled
Tumor-Agnostic

Neoplasms

NCT03276702 2023-06-06

Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies

St. Jude Children's Research Hospital

Completed
8 enrolled
Tumor-Agnostic

Neoplasms

NCT04811794 2022-08-17

Young Survivors at Kantonsspital Aarau, Switzerland

Kantonsspital Aarau

Recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

NCT04428710 2021-02-11

Assessment Psychological Distress for Cancer Heredity Test

Hospital Universitario La Fe

Unknown
800 enrolled

Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡